These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 22313647

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis.
    McKendry RJ, Dale P.
    J Rheumatol; 1993 Nov; 20(11):1850-6. PubMed ID: 8308769
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR, Elliott JR, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, Blakely KM, Hausch R, Leff RD.
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital.
    de Thurah A, Nørgaard M, Johansen M, Stengaard-Pedersen K.
    Scand J Rheumatol; 2010 Feb; 39(1):19-25. PubMed ID: 20132066
    [Abstract] [Full Text] [Related]

  • 9. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
    Lafforgue P, Monjanel-Mouterde S, Durand A, Catalin J, Acquaviva PC.
    J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A.
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years.
    Lim AY, Gaffney K, Scott DG.
    Rheumatology (Oxford); 2005 Aug; 44(8):1051-5. PubMed ID: 15901903
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study.
    Dubey L, Chatterjee S, Ghosh A.
    Indian J Pharmacol; 2016 Aug; 48(5):591-594. PubMed ID: 27721549
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Isoniazid prophylaxis for pulmonary tuberculosis in Chinese patients with rheumatoid arthritis receiving long-term methotrexate therapy].
    Xie QB, Wen FQ, Yin G.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):138-40. PubMed ID: 19292064
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M.
    J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.